Gilead Sciences, Inc.

GILD · NasdaqGS

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders0.1%

Institutions92.4%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$29.44B	$28.75B	$27.12B	$27.28B	$27.30B	$24.69B	$22.45B	$22.13B	$445.00M	$437.00M
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$6.23B	$6.25B	$6.50B	$5.66B	$6.60B	$4.57B	$4.67B	$4.85B	$4.37B	$4.26B
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$10.02B	$1.66B	$7.61B	$7.33B	$9.92B	$4.07B	$4.29B	$8.20B	$14.12B	$17.63B
Operating income as a percentage of revenue.	34.0%	5.8%	28.0%	26.9%	36.3%	16.5%	19.1%	37.1%	3173.9%	4035.0%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$0	$0	-$52.00M	-$26.00M	-$24.00M	-$34.00M	-$22.00M	$5.46B	$4.63B	$13.50B
Net income divided by the number of shares outstanding — profit attributable to each share.	$6.84	$0.38	$4.54	$3.66	$4.96	$0.10	$4.24	$4.00	$3.00	$10.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$6.78	$0.38	$4.50	$3.64	$4.93	$0.10	$4.22	$4.00	$3.00	$9.00

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$7.56B	$9.99B	$6.08B	$5.41B	$5.34B	$6.00B	$11.63B	$17.94B	$7.59B	$8.23B
Everything the company owns that has value — cash, property, inventory, investments, and more.	$59.02B	$58.99B	$62.13B	$63.17B	$67.95B	$68.41B	$61.63B	$63.67B	$70.28B	$56.98B
All of the company's interest-bearing borrowings, short and long term combined.	$24.94B	$26.71B	$24.99B	$25.23B	$26.70B	$31.40B	$24.59B	$27.32B	$33.54B	$26.35B
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$22.70B	$19.33B	$22.83B	$21.24B	$21.07B	$18.20B	$22.52B	$21.39B	$20.44B	$18.89B

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$10.02B	$10.83B	$8.01B	$9.07B	$11.38B	$8.17B	$9.14B	$8.40B	$11.90B	$16.67B
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$563.00M	$523.00M	$585.00M	$728.00M	$579.00M	$650.00M	$825.00M	$924.00M	$590.00M	$748.00M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$9.46B	$10.30B	$7.42B	$8.34B	$10.80B	$7.52B	$8.32B	$7.48B	$11.31B	$15.92B

	You	Peer avg
P/E	–	71.0
Revenue Growth	+10.2%	+3042.9%
ROE	-20.7%	-61.0%

Gilead Sciences, Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Related Market Insights

S&P 500 Q2 2026 Earnings Deliver Record-Breaking Surprises Driven by Tech Giants

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison